Fujifilm Diosynth Biotechnologies provides contract biologics development and manufacturing services. The acquisition included facilities in Research Triangle Park, North Carolina, and Billingham, UK, ...

Pharmaceutical Contract Development & Manufacturing Market by Service {Manufacturing [API, FDF (Parenteral, Tablet, Capsule, Oral Liquid)], Drug Development, Biologics Manufacturing, Packaging ...

SkyQuest projects that the pharmaceutical contract development and manufacturing market will attain a value of USD 222.87 billion by 2030, with a CAGR of 6.9% over the forecast period (2023-2030).

An integrated and agile approach enables the pharmaceutical CDMO industry to simplify manufacturing as it moves from primary care medicines to specialty medicines. Subscribe Generic selectors ...

Biologics contract manufacturing, or BCM, refers to the collaboration between a pharmaceutical company and a specialised third-party service provider, known as a contract development and ...

Industry experts share their views on the outsourcing model and the current and future direction of contract chemical API manufacturing. As fine-chemical companies, contract manufacturers, and ...

Right-shoring and Innovation in Oral Dosage Forms Emerge as Top Growth Opportunities for Small Molecule Contract Development & Manufacturing Organiz Tuesday, 02 January 2024 12:17 GMT عربي ...

Avid Bioservices. Avid Bioservces finished the fiscal year ending April 30 with record-high fourth quarter revenues of $139.911 million, which while down 6% from $149.266 million in FY 2023 ...

LAVAL — Biodextris Inc., a subsidiary of Clean Biologics SAS, announces the development of a industrial-scale vaccine and biologics development, manufacturing and packaging plant (CDMO).

DUBLIN--(BUSINESS WIRE)--The "Global Small Molecule Contract Development and Manufacturing Organization (CDMO) Market Growth Opportunities, 2023" report has been added to ResearchAndMarkets.com's ...